1. Home /
  2. Biotechnology


What's Next for AbbVie Now That It Reached Our Price Target?

Let's review the charts and indicators.

Replimune Breaks Out: Could Rise 30% From Here

Let's check out the charts and indicators of this biotech name.

Moderna's Merck News Will Give a Shot to Its Stock

Word is out that a Moderna experimental melanoma vaccine combined with Merck's Keytruda reduced the risk of relapse in people with skin cancer in a trail.

Let's Take a Technical Peek at Denali Therapeutics

The charts of the biopharmaceutical company that focuses on neurodegenerative diseases indicate short-term caution but long-term promise.

Free Cash Flow Is Key to Business Survival, and It's Why I Like These 2 Stocks

A logistics giant and a small biotech have seen their shares struggle this year, but they are producing solid cash flow and look undervalued.

Pacific Biosciences Has Made a Bottom Pattern: Prices to Watch

The stock bottomed in June/July and have worked higher.

BioVie Shares Higher on Alzheimer Data

Let's check the charts but be prepared for volatility.

Is This the DAWN of a Rally for Day One Biopharmaceuticals?

Let's check the charts after a fundamental buy call.

Here's What to Expect From Biotech in 2023

After a cruel 2022, here are my views on this high-beta sector as we head into the new year.

Intra-Cellular Therapies Has My Attention

We have two price targets.